HUMORAL HYPERCALCEMIA OF MALIGNANCY: INVOLVEMENT OF A NOVEL HORMONE

Australian and New Zealand Journal of Medicine

Volumn 18, Issue 3, 1988, Pages 287-295

  Martin, T John ^a   Rodda, Christine P ^a   Ebeling, Peter R ^a   Kemp, Bruce E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PARATHYROID HORMONE; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR;

CANCER; HUMAN; HYPERCALCEMIA; REVIEW;

EID: 0023739809     PISSN: 00048291     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1988.tb02039.x     Document Type: Article

References (70)

1. Biochemical regulators of bone resorption and their significance in cancer
2. Biochemical evaluation of patients with cancer‐associated hypercalcemia. Evidence for humoral and non‐humoral groups
3. Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer
4. Urinary and nephrogenous adenosine 3′,5′‐monophosphate in the hypercalcemia of malignancy
5. The hypercalcemia of malignancy: Pathogenesis and treatment
6. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcemia in malignancy
7. Case records of the Massachusetts General Hospital (Case 27401)
8. Pseudohyperparathyroidism
9. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia and bronchogenic sarcoma
10. Production of parathyroid hormone by non‐parathyroid tumors
11. Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcemia
12. Parathyroid hormone production and malignancy
13. Hypercalcemia and increased parathyroid hormone activity in a primary hepatoma. Studies before and after hepatic transplantation
14. Synthesis and release of parathyroid hormone by a renal carcinoma in cell culture
15. Hypercalcemia associated with immunoreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (Rhabdoid Wilms' Tumor)
16. Localization of parathyroid hormone‐like substance in squamous cell carcinomas
17. Squamous cell carincoma of the renal pelvis associated with hypercalcemia and the presence of parathyroid hormone‐like substances in the tumor
18. Ectopic hormone production by non‐endocrine tumours
19. Immunological differentiation of primary hyperparathyroidism from hyperparathyroidism due to non‐parathyroid cancer
20. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism
21. Some thoughts on the nature of ectopic parathyroid hormones
22. Non‐parathyroid humoral hypercalcemia in patients with neoplastic disease
23. Secretion of prostaglandins as bone‐resorbing agents by renal cortical carcinoma in culture
24. Prostaglandins: Stimulation of bone resorption in tissue culture
25. 3: A new model for the hypercalcemia of cancer
26. 2 carcinoma model in the rabbit
27. Prostaglandins as mediators of bone resorption in renal and breast tumours
28. Breast cancer osteolysis, bone metastases and antiosteolytic effect of aspirin
29. Failure of indomethacin to reduce hydroxyproline excretion or hypercalcemia in patients with breast cancer
30. Prostaglandins in bone and mineral metabolism
31. 2 raises plasma calcium concentration in the rat
32. Hypercalcemia of malignancy
33. Bone resorbing activity in supernatants from cultured human peripheral blood leukocytes
34. Evidence for the secretion of an osteoclast stimulating factor in myeloma
35. Bone‐resorbing activity in supernatants from lymphoid cell lines
36. An interleukin l‐like factor stimulates bone resorption in vitro
37. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors
38. Production of lymphotoxin, a bone‐resorbing cytokine, by cultured human myeloma cells
39. Isolation of a bone‐resorptive factor from human cancer ascites fluid
40. Tumor products and the hypercalcemia of malignancy
41. Epidermal growth factor stimulates prostaglandin and bone resorption in cultured mouse calvaria
42. Direct stimulation of bone resorption by epidermal growth factor
43. Autocrine secretion and malignant transformation of cells
44. Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF
45. Tumor‐derived growth factor increased bone resorption in a tumor associated with humoral hypercalcemia of malignancy
46. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms
47. Stimulation of bone resorption in vitro by synthetic transforming growth factor‐alpha
48. Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria
49. Actions of epidermal growth factor on plasma calcium. Epidermal growth factor and human transforming growth factor‐alpha cause elevation of plasma calcium in mice
50. Bone and kidney adenylate cyclase‐stimulating activity produced by a hypercalcaemia canine adenocarcinoma line (CAC‐S) maintained in nude mice
51. Co‐purification of a transforming growth factor (TGF) with bone resorbing activity in the Walker rat carcinosarcoma: A mechanism for the humoral hypercalcemia of malignancy (HHM)
52. Identification of adenylate‐cyclase‐stimulating activity and cytochemical glucose‐6‐phosphate dehydrogenase‐stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy
53. Facotrs associated with humoral hypercalcemia of malignancy stimulate adenylate cyclasc in osteoblastic cells
54. Messenger ribonucleic acid from tumors associated with humoral hypercalcemia of malignancy directs the synthesis of a secretory parathyroid hormone‐like peptide
55. Malignancy‐associated hypercalcemia: Evaluation with a cytochemical bioassay for parathyroid hormone
56. Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognised by parathyroid hormone receptors
57. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin
58. Characterization of an osteoblast‐like clonal cell line which responds to both parathyroid hormone and calcitonin
59. Immunoreactive calcitonin by human lung cancer cells in culture
60. Parathyroid hormone‐related protein purified from a human lung cancer cell line
61. Molecular cloning and expression of a novel hormone cDNA encoding a parathyroid hormone‐like protein in human lung cancer cells
62. Prediction of sequential antigenic regions in proteins
63. A parathyroid hormone‐like protein from cultured human keratinocytes
64. Factor related to humoral hypercalcemia of malignancy in sheep placenta
65. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases
66. Mechanisms of malignant hypercalcemia in carcinoma of the breast
67. Identification of a novel 17,000‐dalton parathyroid hormone‐like adenylate cyclase‐stimulating protein from a tumor associated with humoral hypercalcemia of malignancy